Work

Additional file 1: Figure S1. of Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer

Year: 2016

Type: article

Abstract: HCC70 (A) or SUM149 (B) cells were treated with single-agent gefitinib (left) or combination treatment with 5 ÎźM LY294002 plus gefitinib at the concentrations indicated and cell proliferation measured over 4 days. (PDF 217 kb)

Source: Figshare

DOI: 10.6084/m9.figshare.4352948

Authors: She, Qing-Bai, Gruvberger-Saal, Sofia, Maurer, Matthew, Chen, Yilun, Jumppanen, Mervi, Su, Tao, Dendy, Meaghan, Lau, Ying-Ka, Memeo, Lorenzo, Horlings, Hugo, van de Vijver, Marc, Isola, Jorma, Hibshoosh, Hanina, Rosen, Neal, Parsons, Ramon, Saal, Lao

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7138389688

FWCI:

Cites:

Cited by:

Related to: 10